Ram Aiyar - 29 May 2026 Form 4 Insider Report for Korro Bio, Inc. (KRRO)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Jun 2026, 07:00:03 UTC
Prior SEC filing
28 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jeffrey Cerio, Attorney-in-fact

Key filing fact

Ram Aiyar filed Form 4 for Korro Bio, Inc. (KRRO) on 02 Jun 2026.

Key facts

  • This page summarizes Ram Aiyar's Form 4 filing for Korro Bio, Inc. (KRRO).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Jun 2026, 07:00.

Change

  • Previous filing in this sequence was filed on 28 May 2026.
  • Current net transaction value: -$196,673.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001997920 Primary reporting owner

Aiyar Ram

Relationship
President and CEO, Director
Address
C/O KORRO BIO, INC., 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE
Signature
/s/ Jeffrey Cerio, Attorney-in-fact
Signature date
02 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KRRO transaction

Common Stock

Sale

Transaction value
$196,673
Shares
-15,152
Change %
-17%
Price
$12.98
Shares after
74,848
Date
29 May 2026
Ownership
Direct
Footnotes
F1, F2, F3
KRRO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,613
Date
29 May 2026
Ownership
Shares are held by The Ram Aiyar Irrevocable Trust.
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents the sale of shares of common stock solely to satisfy tax withholding obligations incurred upon vesting and settlement of a performance stock unit.

Footnote F2

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions at prices ranging from $12.62 to $13.245, inclusive. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request.

Footnote F3

Includes 40,000 shares of common stock issuable upon settlement of a restricted stock unit granted under the 2023 Plan as reported on Form 4 dated February 3, 2026.

Footnote F4

Shares held by The Ram Aiyar Irrevocable Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .